Storia della carriera di Fabrizio Giannotta
Precedenti posizioni note di Fabrizio Giannotta
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
ProGenosis SA
 ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Amministratore Delegato | 29/06/2006 | - |
| Fondatore | 02/11/2009 | - |
Formazione di Fabrizio Giannotta
| University of Liege | Doctorate Degree |
Statistiche
Distribuzione geografica
| Belgio | 3 |
Posizioni
| Chief Executive Officer | 1 |
| Founder | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
ProGenosis SA
ProGenosis SA Pharmaceuticals: MajorHealth Technology ProGenosis SA operates as a biotechnology company which develops bifunctional hybrid proteins. It offers antibody characterization, antibody development, and protein expression services to life science companies. The company’s bifunctional hybrid proteins are used for protein domain studies, as well as used as secondary detection agent for lactamase-amplified enzyme-linked immunosorbent assays. ProGenosis was founded by Fabrizio Giannotta and Jean-luc Herbos in 2006 and is headquartered in Sart-Tilman, Belgium. | Health Technology |
- Borsa valori
- Insiders
- Fabrizio Giannotta
- Esperienza
